Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients

NCT01418846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2015-01-13

No results posted yet for this study

Summary

The purpose of this study is to investigate the intra-saliva penetration of voriconazole in different subpopulations. The goal is to develop, optimize and validate an easy, non-invasive and painless procedure for Therapeutic Drud Monitoring of voriconazole that can be used in children, ambulatory patients and in patients in whom blood drawing is difficult.

Conditions

  • Pneumology
  • Hematology
  • Internal Medicine
  • Pediatrics

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Kim Vanstraelen, R.Ph. · Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-06-30
Completion
2014-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01418846 on ClinicalTrials.gov